Thorac Cardiovasc Surg 2022; 70(S 02): S67-S103
DOI: 10.1055/s-0042-1743011
Oral and Short Presentations
Monday, February 21
DGPK Short Reports

Targeted Temperature Management Protects Microglia from Ischemia/Reperfusion-Induced Necrosis and Attenuates the Release of Mediators of Sterile Inflammation

N. Rolfs
1   Deutsches Herzzentrum Berlin, Berlin, Deutschland
,
G. Tong
2   Department of Congenital Heart Disease/Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Deutschland
,
J. Lücht
2   Department of Congenital Heart Disease/Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Deutschland
,
S. Wowro
1   Deutsches Herzzentrum Berlin, Berlin, Deutschland
,
K. R.L. Schmitt
2   Department of Congenital Heart Disease/Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Deutschland
› Institutsangaben

Background: Ischemic brain injury results in the release of damage-associated molecular patterns (DAMPs) and endogenous mediators of sterile inflammation. Targeted temperature management (TTM) is neuroprotective via induced intracellular cold-shock RBM3 and CIRBP expression. However, extracellular CIRBP has been implicated as a mediator of sterile inflammation. Microglia mediated neuroinflammation has been well investigated as both detrimental and regenerative properties have been described for these cells. Still the effect of TTM on microglia activation and DAMPs release after ischemia/reperfusion (I/R) injury remains to be elucidated. Comprehension of the role of microglia in I/R-induced sterile inflammation is needed to improve the efficacy of TTM. Therefore, we investigated the effect of cooling on cell viability, DAMPs release, and inflammation in I/R injured microglia.

Method: BV-2 microglia were exposed to 2 to 6 hours of oxygen-glucose deprivation (OGD, 0.2% oxygen in glucose/serum-free medium) followed by 3 to 19 hours of reperfusion (21% oxygen in complete medium). Cells were maintained at either normothermia (37°C) or cooled to 33.5°C (TTM) 1 hour after experimental start. Necrosis was assessed by LDH release and apoptosis by Caspase-3/-8/-9 cleavage. Intra/extracellular DAMPs (CIRBP, Hsp70, and HMGB-1) and antiapoptotic RBM3 were evaluated by the Western Blot. Oxidative stress (iNOS), inflammatory cytokines (TNF-a, IL-1a/-1b, IL-6, and IL-10), and microglial activation markers (AIF1 and MCP-1) were assessed by RT-qPCR.

Results: TTM attenuated I/R-induced necrosis but not OGD-induced oxidative stress (iNOS) in the microglia. We also observed significant inductions of neuroprotective RBM3 and, even more rapidly, CIRBP by cooling. Moreover, OGD-induced DAMPs release was also attenuated by cooling and correlated with degree of necrosis, suggesting a passive secretion mechanism in the microglia. Exposure to OGD suppressed most cytokine gene expressions independently of temperature management. Interestingly, cooled Normoxia groups had significant increase of microglial activation marker, Iba1, IL-1b, as well as TNF-a gene expressions.

Conclusion: TTM conveyed neuroprotection as observable in increased cell viability, attenuated DAMPs release, and induced expression of cold shock proteins in I/R injured microglial cells. As cooling alone resulted in both upregulated expression of proinflammatory cytokines, as well as of neuroprotective cold shock proteins, TTM might have ambiguous effects in sterile inflammation.



Publikationsverlauf

Artikel online veröffentlicht:
12. Februar 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany